These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21965303)

  • 1. Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway.
    Zhou Y; Zhang E; Berggreen C; Jing X; Osmark P; Lang S; Cilio CM; Göransson O; Groop L; Renström E; Hansson O
    Hum Mol Genet; 2012 Jan; 21(1):196-207. PubMed ID: 21965303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells.
    Shao W; Szeto V; Song Z; Tian L; Feng ZP; Nostro MC; Jin T
    J Mol Endocrinol; 2018 Jul; 61(1):1-12. PubMed ID: 29678908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets.
    Shu L; Sauter NS; Schulthess FT; Matveyenko AV; Oberholzer J; Maedler K
    Diabetes; 2008 Mar; 57(3):645-53. PubMed ID: 18071026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCF7L2 splice variants have distinct effects on beta-cell turnover and function.
    Le Bacquer O; Shu L; Marchand M; Neve B; Paroni F; Kerr Conte J; Pattou F; Froguel P; Maedler K
    Hum Mol Genet; 2011 May; 20(10):1906-15. PubMed ID: 21357677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1 binds to the rs7903146 locus in TCF7L2 in human pancreatic islets.
    Zhou Y; Oskolkov N; Shcherbina L; Ratti J; Kock KH; Su J; Martin B; Oskolkova MZ; Göransson O; Bacon J; Li W; Bucciarelli S; Cilio C; Brazma A; Thatcher B; Rung J; Wierup N; Renström E; Groop L; Hansson O
    Mol Cell Endocrinol; 2016 Jul; 430():138-45. PubMed ID: 26845344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
    Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
    Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism.
    Norton L; Fourcaudot M; Abdul-Ghani MA; Winnier D; Mehta FF; Jenkinson CP; Defronzo RA
    Diabetologia; 2011 Dec; 54(12):3132-42. PubMed ID: 21901280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.
    da Silva Xavier G; Loder MK; McDonald A; Tarasov AI; Carzaniga R; Kronenberger K; Barg S; Rutter GA
    Diabetes; 2009 Apr; 58(4):894-905. PubMed ID: 19168596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCF7L2 is a master regulator of insulin production and processing.
    Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
    Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Pericytes Support β-Cell Function in a Tcf7l2-Dependent Manner.
    Sakhneny L; Rachi E; Epshtein A; Guez HC; Wald-Altman S; Lisnyansky M; Khalifa-Malka L; Hazan A; Baer D; Priel A; Weil M; Landsman L
    Diabetes; 2018 Mar; 67(3):437-447. PubMed ID: 29246974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geniposide promotes beta-cell regeneration and survival through regulating β-catenin/TCF7L2 pathway.
    Yao DD; Yang L; Wang Y; Liu C; Wei YJ; Jia XB; Yin W; Shu L
    Cell Death Dis; 2015 May; 6(5):e1746. PubMed ID: 25950476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals.
    Le Bacquer O; Kerr-Conte J; Gargani S; Delalleau N; Huyvaert M; Gmyr V; Froguel P; Neve B; Pattou F
    Diabetologia; 2012 Oct; 55(10):2677-2681. PubMed ID: 22911383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor protein p53-induced nuclear protein 1 (TP53INP1) in spontaneous chronic pancreatitis in the WBN/Kob rat: drug effects on its expression in the pancreas.
    Jiang PH; Motoo Y; Iovanna JL; Pébusque MJ; Xie MJ; Okada G; Sawabu N
    JOP; 2004 Jul; 5(4):205-16. PubMed ID: 15254349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-205 is up-regulated in islets of diabetes-susceptible mice and targets the diabetes gene Tcf7l2.
    Ouni M; Gottmann P; Westholm E; Schwerbel K; Jähnert M; Stadion M; Rittig K; Vogel H; Schürmann A
    Acta Physiol (Oxf); 2021 Aug; 232(4):e13693. PubMed ID: 34028994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
    Loder MK; da Silva Xavier G; McDonald A; Rutter GA
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice.
    da Silva Xavier G; Mondragon A; Mourougavelou V; Cruciani-Guglielmacci C; Denom J; Herrera PL; Magnan C; Rutter GA
    Diabetologia; 2017 Jun; 60(6):1043-1050. PubMed ID: 28343277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor-7-like 2 (
    Nguyen-Tu MS; da Silva Xavier G; Leclerc I; Rutter GA
    J Biol Chem; 2018 Sep; 293(36):14178-14189. PubMed ID: 29967064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway.
    Cui J; Duan J; Chu J; Guo C; Xi M; Li Y; Weng Y; Wei G; Yin Y; Wen A; Qiao B
    Aging (Albany NY); 2020 Jan; 12(2):1591-1609. PubMed ID: 31969494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
    Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA
    Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro scan for enhancers at the TCF7L2 locus.
    Savic D; Park SY; Bailey KA; Bell GI; Nobrega MA
    Diabetologia; 2013 Jan; 56(1):121-5. PubMed ID: 23011354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.